The Y chromosome is a genetic and evolutionary enigma. In groups like mammals and Drosophila with advanced systems of chromosomal sex determination, the Y lacks most of the thousands of genes carried on its pairing partner at meiosis, the X chromosome. Comparative studies suggest strongly that the X and Y chromosomes were originally largely homologous, probably differing by only a few genes concerned with sex determination [1] [2] [3] . Degeneration of most of the genes on the Y chromosome has happened repeatedly, in dozens of independent lineages. It is commonly believed that evolution makes things better not worse: why, then, should such a substantial fraction of the genome have degenerated in this way?
The genetic erosion of the Y chromosome must have been an evolutionary response to the observed suppression of recombination between most of the X and Y, which allows them to evolve independently. As the X can recombine freely in the homogametic sex, whereas the Y is transmitted as a permanently heterozygous, largely or completely non-recombining unit, there is an asymmetry in the evolutionary forces operating on them. The smaller number of copies of the Y in the population as a whole renders it more vulnerable to the effects of genetic drift. Its lack of genetic recombination means that natural selection is less effective in preventing the accumulation of deleterious mutations or promoting the spread of advantageous ones [2, 3] .
In several groups with 'degenerate' Y chromosomesDrosophila, Sciarids, Orthoptera, mammals and nematodes -the halving of gene dosage for most X-linked loci in the heterogametic sex is known to be compensated for by different levels of expression of these genes in the two sexes, such that the net amount of X-linked gene product is the same in the two sexes. The evolution of dosage compensation is probably a response to the loss of gene activity on the Y: if the level of functioning of a Y-linked gene is low relative to that of its X-linked partner, it will be selectively advantageous for the heterogametic sex to increase the relative level of activity of the X-linked copy [1] [2] [3] [4] .
Recent studies of the molecular genetics of mammalian sex chromosomes are starting to shed light on the details of the way in which Y chromosomes have evolved, and the relation between their degeneration and dosage compensation. The basic organization of the human Y chromosome is now well understood, and most of the functioning genes on this chromosome have probably been identified ( Figure 1 ) [5, 6] . A recent screen of testis cDNA with human Y chromosomal DNA recovered 12 new genes, all which proved to be located on the non-recombining portion of the Y. Five of these are single copy genes, each with an X-linked homologue that codes for a similar protein sequence, and which are apparently expressed in a wide range of tissues [6] . The other genes on the Y appear to lack homologues on the X, and are testis-specific in their expression ( Figure 1 ).
While it is easy to imagine reasons why genes with malespecific effects might be sequestered on the Y [2, 3, 6] , the existence of shared genes on the non-recombining portion of the Y is not so easily understood. Why should there be functional genes in common between the X and Y, outside the pseudoautosomal regions where recombinational exchange ensures that the two chromosomes share genetic information? The most likely interpretation is that these are genes whose Y-linked copies have simply not degenerated There are several possible explanations for such lack of degeneration, which are not mutually exclusive. It could be because degeneration is the product of stochastic processes with inherent rate variability, because the fitness effects of loss of the function of the Y-linked copies are too large to be tolerated, or because they are relatively recent arrivals on the sex chromosomes and have not had time to degenerate. The last possibility is supported by evidence for several additions of autosomal material to mammalian sex chromosomes over evolutionary time [7] . In any of the three cases, there should be no evidence for dosage compensation of the genes, as dosage compensation of a locus is thought to be an evolved response to the degeneration of its Y-linked homologue. As expected, all X-linked genes with Y-linked homologues seem not to be dosage compensated in humans [6] .
The question of the relation between dosage compensation and the retention of homology between X-linked and Y-linked copies of the same locus has been pursued more recently in a broader phylogenetic perspective [8] . As is well known, dosage compensation in mammals involves the inactivation of one of the two X chromosomes in somatic cells of females, such that nearly all genes on one randomly selected chromosome are not transcribed. Jegalian and Page [8] studied the X-inactivation of four Xlinked genes -ALD, ZFX, RPS4X and SMCX -by assaying the extent of methylation of sequences within these genes known as 'CpG islands', in adult tissues from a range of mammalian species. Previous studies have demonstrated a close relation between methylation of an X-linked allele and its inactivation, so that a detectable level of methylation of an X-linked gene in females but not males is indicative of X-inactivation.
ALD showed the simplest pattern: it was X-inactivated in all 18 species investigated (selected from nine orders of eutherian mammals). In the case of ZFX, there was evidence for methylation only in myomorph rodents (mouse, rat, hamster and lemming); no methylation was found in species from ten other orders of eutherian mammals. This suggests that ZFX was not originally subject to X-inactivation, and has only become inactivated in rodents. In contrast, RPS4X is inactivated in all eight non-primate species tested, but is not inactivated in any of the eight primate species tested. Finally, SCMCX is inactivated in five out of eleven eutherian orders, not including primates and myomorphs.
ALD, which lacks a Y-linked copy, presumably experienced erosion of this copy before the radiation of eutherians. ZFX has a strongly conserved homologue, ZFY, in all groups except myomorph rodents, whose ZFY sequences seem to have diverged considerably from that of ZFX. This suggests that ZFX was not X-inactivated in ancestral eutherians, and that functionality of the Y-chromosomal copy has been retained in all groups studied other than myomorph rodents, where it has either lost function or diverged in function from ZFX, thereby promoting the evolution of dosage compensation of its homologue. RPS4X, in contrast, seems to have retained a Y-linked homologue only in primates, consistent with its pattern of X-inactivation. SCMX shows a more complex pattern. As predicted, there is no Y-linked homologue in cattle and guinea pigs, which both show dosage compensation. In rabbits and goats, however, a male-specific homologue is detectable by Southern blotting, despite the fact that SCMX shows X-inactivation. But screening of rabbit cDNA libraries shows no evidence for SCMY clones, suggesting that the gene is not expressed at a high level.
Overall, therefore, there is a good correlation between dosage compensation of an X-linked gene in a mammalian species and absence of an active Y-linked homologue, although some details remain to be clarified. This is consistent with models for the evolution of dosage compensation on a gene-by-gene basis [2, 3, 9] , rather than by a mechanism involving coordinated changes in activity over large chromosomal regions. Consistent with this, there are numerous human X-linked genes that do not undergo X inactivation, but which lack Y-linked homologues [10] . This also indicates that dosage compensation is not an inevitable concomitant of loss of Y-gene function.
But to explain the inactivation in females of an X-linked gene whose Y-linked homologue has degenerated in males, one further postulate must be added: the evolution of increased activity of the X-linked copy must have occurred in both females and males. If this happens, there is then a selective advantage to reduced X-chromosomal gene activity in females, thereby restoring the normal level of gene product. This seems logically inescapable [2, 8] , but there is only one observation supporting such a scenario. The Clc4 gene in the mouse Mus spretus is X-linked, whereas it is autosomal in the close relative M. musculus. Analysis of mRNA production in backcross individuals from species hybrids indicates that the X-linked copy of Clc4 is twice as active as the autosomal copy in both males and females, suggesting that the copy that has apparently been moved to the X has acquired enhanced gene activity [11] . It is not known whether this is an automatic consequence of removal to the X chromosome, which would suggest a general upregulation of X-linked genes. Transgenic introductions of autosomal genes onto the X might illuminate this point. 
